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1. Introduction
  Ischemic tolerance is the most powerful endogenous 
protective mechanism against ischemia injury. Hypoxia-
inducible factor-1alpha (HIF-1毩) is a transcription 
factor closely related to ischemic tolerance. There is 
evidence that HIF-1毩 exhibits strong protective effects on 
hypoxic-ischemic brain damage by promoting anaerobic 
metabolism of brain cells, vasoformation, oxygen transport 
of erythrocytes, improving energy metabolism disorder, 
haemodynamic recovery, and reducing cell apoptosis after 
cerebral ischemia[1]. The mechanism by which HIF-1毩 
protects endogenous neural stem cells (NSCs) from cerebral 
hemorrhage remains poorly understood. In this study, we 
injected recombinant adenovirus (Ad) carrying HIF-1毩 
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Zhen Yu et al./Asian Pacific Journal of Tropical Medicine (2013)762-767 763
gene (Ad-HIF-1毩) into the hemorrhagic ventricle of rat 
models of intracerebral hemorrhage (ICH) established by 
autologous blood injection, labeled cells in S phase with 
5-bromo-2’-deoxyuridine (BrdU), scored neurological 
deficits and detected DCX and BrdU expression in the 
hemorrhagic tissue by immunohistochemical staining. 
We studied the effects of HIF-1毩 gene on proliferation, 
migration and differentiation of endogenous NSCs and the 
underlying mechanism, correlated HIF-1毩 with cerebral 
ischemia, and investigated the therapeutic effects of 
recombinant adenovirus-mediated HIF-1毩 on ICH in rats, 
providing a new method for the treatment of ICH. 
2. Materials and methods
2.1. Animals
  A total of 120 specific pathogen-free, adult, male Sprague-
Dawley rats, weighing 270-320 g, provided by Laboratory 
Animal Center, Third Military Medical University of 
Chinese PLA, were included in this study. All experimental 
procedures were performed in strict accordance with the 
Regulations for the Administration of Affairs concerning 
Experimental Animals issued by the State Council of 
China in 1988. Three groups, Ad-HIF-1毩, Ad and PBS, 
were designated (n = 40). Immediately after establishing 
ICH models, rats in the Ad-HIF-1毩, Ad and PBS groups 
received 10 毺L of Ad-HIF-1毩 (1暳10
8 pfu), Ad (1暳10
8 pfu) 
or sterile PBS respectively via the ischemic ventricle.  
2.2. Main reagents and instruments 
  Ad empty vector and Ad-HIF-1毩 were gifted by Dr. 
Tao Tao from Department of Neurology, Second Affiliated 
Hospital of Chongqing Medical University, China. Nestin 
BD was purchased from BD Biosciences Pharmingen (San 
Diego, CA, USA), glial fibrillary acidic protein (GFAP) from 
Thermo Fisher Scientific Inc., (Rockford, IL, USA), NeuN 
from Chemicon (Billerica, MA, USA), doublecortin (DCX) 
from Cell Signaling Technology Inc., (Danvers, MA, USA), 
and 5-bromo-2’-deoxyuridine (BrdU) from Sigma (St. Louis, 
MO, USA). Rat stereotaxic instrument was provided by Xi’an 
Optical Medical Instrument Co., Ltd., (Xi’an, China) and 
microinjector by Shanghai Anting Microsyringe Factory 
(Shanghai, China). 
2.3. Establishment of ICH models in rats 
  After anesthesia, rats were placed in a stereotaxic 
instrument in the prone position. According to a previously 
described method, a medial skin incision was made over 
the skull to expose the bregma. A pore with a diameter of 
approximately 1 mm was drilled at 0.2 mm anterior to the 
bregma and 3.5 mm right lateral to the midline. Rat tail 
was cut off at 5 mm away from the tail end and 75毺L blood 
was taken through the use of microinjector to establish 
ICH models with similar sized hematomas. Then, the 
microinjector was fixed in the stereotaxic instrument and 
inserted into the pore at the depth of 5.5 mm and maintained 
in place for 10 min.   
2.4. Stereotaxic injection into the ventricle
  Rats were administered 10 毺L of PBS, Ad or Ad-HIF-1
毩 using the microinjector into the site 1.5 mm posterior 
to bregma, 2 mm right lateral to the midline, and 3.5 mm 
below the dura mater within 10 min. The microinjector was 
left in place for 10 min and then slowly withdrawn. The pore 
was sealed with bone wax and scalp was sutured layer by 
layer. The local skin was disinfected with iodine tincture 
for preventing infection. Rat body temperature, heart rate 
and respiratory frequency were monitored continuously 
throughout the experiment.
2.5. BrdU labeling
  BrdU solution (5暳10
3 g/L) prepared by saline was 
intraperitoneally administered at 50 mg/kg, once every 12 h,
for a total of 2 successive days. Rats were sacrificed 24 h 
after the last BrdU (5暳10
3 g/L) administration for detecting 
cell proliferation changes of normal cells and injured 
cells over time course. BrdU solution (5暳10
3 g/L) prepared 
by saline was intraperitoneally administered at 50 mg/kg
12 h after ICH, once per day, for a total of 14 d. Rats were 
sacrificed 14 d after the last BrdU solution (5暳10
3 g/L)
administration (ie., day 28 after ICH) for detecting the 
differentiation of new generally cells. 
2.6. Assessment on improvement in neurological functions 
  On the 1st, 7th, 14th, 21st and 28th d after surgery, rat 
neurological deficits were scored using Neurological 
Severity Score (NSS). Rats that could not perform above tasks 
or lacked of corresponding reflex were scored 1. Scores 
1-6 indicate mild neurological deficits, 7-12 moderate 
neurological deficits, and 13-18 severe deficits.  
2.7. Preparation of tissue sections
  At postoperative 4 h, 1, 3, 7 d, rat thoracic cavity was 
opened to expose the heart under anesthesia by 10% chloral 
hydrate (0.35 mL/100 g). The needle was inserted into 
the aorta from the cardiac apex and via the left ventricle 
and then fixed. An aliquot of 200 mL normal saline was 
rapidly perfused and simultaneously a cut was made in 
the right atrium. After blood was washed away, 300 mL 
4% paraformaldehyde was perfused at 4 曟. Following 
craniotomy, the brain was harvested and fixed in the 
fixing solution for 48 h at 4 曟. Then the brain tissue was 
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transferred to 30% sucrose until it sank to the bottom. After 
one PBS wash and OCT embedding, a brain tissue block 
spanning across 3 mm anterior to 5 mm posterior from 
anterior border of the optic chiasma was removed through 
the use of freezing microtome. The brain tissue block, 
containing cerebral cortex and dorsal caudate putamen, was 
sliced into 16毺m thick coronal sections. 
2.8. DCX and BrdU immunohistochemical staining  
  Tissue sections were washed with 0.01 M PBS three times 
for 5 min each, incubated with 3% H2O2 for 15-30 min to 
inactivate endogenous peroxidase, blocked with normal 
goat serum for 30 min and then incubated overnight after 
addition of rabbit anti-DCX (1: 200) and anti-BrdU (1: 500) 
antibodies. After three washes with 0.01 M PBS for 5 min 
each, tissue sections were incubated with biotinylated goat 
anti-rabbit IgG (1:100) or goat anti-IgG (1:100) antibodies at 
37 曟 for 3 h. After three washes with 0.01 M PBS for 5 min
each, tissue sections were incubated with SABC (1:100) at 
37 曟 for 2 h. Then, tissue sections were developed with 
3,3’-diaminobenzidine, dehydrated in ethanol gradients, 
cleared , mounted with neutral gel and finally observed 
under optical microscope. For negative control, PBS served 
as primary antibody, and the remaining procedures were the 
same as above.  
2.9. Double immunofluorescent labeling
  Tissue sections were washed with 0.01 M PBS three times 
for 5 min each, treated with 0.1% Triton for 30 min, blocked 
with normal goat serum for 30 min, incubated with primary 
antibody rat anti-BrdU antibody (1: 500) at 4 曟 overnight, 
with fluorescent secondary antibody goat ant-rabbit TRITC 
(1:100) at 37 曟 for 1 h, with primary antibodies rabbit anti-
DCX (1:200), rabbit ant-GFAP (1:200) or rabbit anti-CD31 
(1:200) antibodies at 37 曟 for 1 h in the dark, and with 
fluorescent secondary antibody goat anti-rat FITC (1:100) 
antibody. Three PBS washes for 5 min each were used for 
all intermittent steps. Then tissue sections were left at room 
temperature in the dark for 2 h and air dried. Finally, they 
were observed under the fluorescent microscope. For the 
negative control, PBS served as the primary antibody, and 
the remaining procedures were the same as above. 
2.10. Immunohistochemical observation results and statistical 
analysis
  F ive  ra t s  were  se lec ted  f rom each  g roup  f o r 
immunohistochemical observation. Ten sections per rat 
were randomly selected. Under 200-fold magnification, 
five fields of view in each section were randomly selected 
for cell counts. All data were expressed as mean暲SD and 
statistically processed with SPSS 11.5 software. Analysis of 
variance was used for comparison between groups. t-test 
was used for pairwise comparison at the same time point.  A 
level of 毩=0.05 was considered statistically significant.  
 
3. Results
3.1. Neurological deficit assessment by NSS
  There was no significant difference in neurological deficit 
scores at 1 d after ICH between Ad-HIF-1毩 and Ad groups 
(P > 0.05), but significant differences existed between Ad-
HIF-1毩 and PBS groups or between Ad and PBS groups 
(P < 0.01). At 7-28 d after ICH, neurological deficit scores 
in the Ad-HIF-1毩 group were significantly lower than in 
the Ad and PBS groups (both P < 0.01), while there was no 
significant difference in neurological deficit scores between 
Ad and PBS groups (all P > 0.05) (Figure 1).
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Figure 1. Comparison of NSS among groups.
 *P<0.01 for PBS group vs. Ad group; 吟P > 0.05 for Ad group vs. PBS 
groups.
3.2. DCX immunohistochemical staining results
  DCX-positive cells were primarily located in the ipsilateral 
subventricular zone and the tissue surrounding the corpus 
callosum. They were slightly increased on the 3rd d after 
ICH, significantly increased on the 7th d, peaked on the 
14th d, and then gradually decreased. On the 7th, 14th and 
28th d after ICH, the number of DCX-positive cells in the 
Ad-HIF-1毩 group was significantly greater than in the Ad 
group (P < 0.05) (Figures 2-5). 
A                                              B                                              C
 
Figure 2. Immunohistochemical detection of DCX-positive cells in 
the subventricular zone after intracerebral hemorrhage. 
From left to right (A-B-C): PBS, Ad and Ad-HIF-1毩 groups, 
respectively. Bar=50 毺m. 
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Figure 3. Comparison of DCX-positive cells in the subventricular 
zone at different time points after intracerebral hemorrhage. 
(*P<0.01 for Ad-HIF-1毩 group vs. PBS group; #P<0.01 for Ad-HIF-1
毩 group vs. Ad group; 吟P >0.05 for Ad group vs. PBS group.
A                                              B                                              C
Figure 4. Immunohistochemical detection of DCX in the corpus 
callosum after ICH. 
From left to right (A-B-C): PBS, Ad, Ad-HIF-1毩 groups respectively. 
Bar=50 毺m.
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Figure 5. Comparison of DCX-positive cells in the corpus callosum 
of rats from each group at different time points after intracerebral 
hemorrhage.
 *P<0.01, #P<0.05,吟P>0.05 for PBS group vs. Ad group; *P<0.01, 
#P<0.05, 吟P>0.05 for Ad group vs. PBS group. 
3.3. BrdU immunohistochemical staining results
  BrdU-positive cells could be seen in the subventricular 
zone of rats in the PBS, Ad and Ad-HIF-1毩 groups. In 
each group, BrdU-positive cells increased on the 3rd d after 
ICH, peaked on the 7th d and gradually decreased after 
14 d. In the Ad-HIF-1毩 group, BrdU-positive cells were 
significantly increased over time course, and significant 
difference in BrdU-positive cell counts was observed when 
compared with the PBS and Ad groups at each time point (P 
< 0.01 or 0.05) (Figure 6, 7). 
A                                              B                                              C
Figure 6. Immunohistochemical detection of BrdU in the 
subventricular zone of rats from each group after intracerebral 
hemorrhage. 
From left to right (A-B-C): PBS, Ad and Ad-HIF-1毩 groups, 
respectively. Bar=50 毺m. 
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Figure 7. Comparison of BrdU-positive cells in the subventricular 
zone of rats from each group at different time points after intracerebral 
hemorrhage.
**P<0.05 for PBS group vs. Ad group; 吟P>0.05 for Ad group vs. PBS 
group.
 
3.4. BrdU/DCX and BrdU/GFAP immunofluorescent double 
staining results 
  The differentiation of newly generated cells was detected 
by BrdU/DCX and BrdU/GFAP immunofluorescent double 
staining method. Results showed that BrdU/DCX- and BrdU/
GFAP-positive cells were observed in the subventricular 
zone of rats in each group on the 28th d after ICH, and the 
number of BrdU/DCX- and BrdU/GFAP-positive cells in the 
Ad-HIF-1毩 group was significantly greater than that in the 
Ad group (P < 0.05) (Figure 8-11). 
A                                              B                                              C
Figure 8. DCX/BrdU double immunofluorescent staining of the 
peri-hematoma tissue under the confocal laser scanning electron 
microscope. 
(A) DCX-positive cells; (B) BrdU-positive cells; (C) merge of (A) and (B). 
Nuclei were stained with DAPI. Bar=50 毺m.
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Figure 9. Comparison of BrdU/DCX-positive cells in the peri-
hematoma tissue of rats in each group at day 28 after intracerebral 
hemorrhage.
#P<0.05 for PBS group  vs. Ad group; 吟P>0.05 for Ad group vs. PBS 
group.
A                                              B                                              C
Figure 10. GFAP/BrdU double immunofluorescent staining of the 
peri-hematoma tissue under the confocal laser scanning electron 
microscope. 
(A) GFAP-positive cells; (B) BrdU-positive cells; (C) merge of (A) and (B). 
Nuclei were stained with DAPI. Bar=50 毺m.
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Figure 11. Comparison of BrdU/GFAP-positive cells in the peri-
hematoma tissue of rats in each group at day 28 after intracerebral 
hemorrhage.
#P<0.05 for PBS group  vs. Ad group; 吟P>0.05 for Ad group vs. PBS 
group.
4. Discussion
  Endogenous HIF-1毩 has no ability to protect the brain 
against cerebral hemorrhage because of its not enough 
expression and short action time. Recombinant adenovirus-
transfected HIF-1毩 gene can maintain high level of HIF-1
毩 in the peri-hematoma brain tissue, infect differentiated 
and undifferentiated cells, and thereby exhibit therapeutic 
effects on ICH.  
  Studies have demonstrated that neural precursor cells 
exist in the subventricular zone, hippocampal dentate 
gyrus, and cerebral cortex[2,3]. All kinds of brain injuries, 
including cerebral infarction, can induce neurogenesis[4,5]. 
Neurogenesis following experimental cerebral infarction can 
facilitate recovery from brain injuries[6]. Neurogenesis can 
be induced in rat models of subarachnoid hemorrhage or 
collagenase-induced ICH[7,8]. Our results also demonstrated 
that neurogenesis could be also induced in rat models 
established by autologous blood injection and lasted over 4 
weeks. This suggests that neurogenesis exists long time after 
ICH and HIF-1毩 exerts an important role in ICH-induced 
neurogenesis.
  HIF-1毩 plays an important role in the proliferation 
of embryonic stem cells and the development of fetal 
rats; HIF-1毩 gene knockout can cause death of a large 
number of brain cells and neural tube defects[9]. HIF-1
毩 gene knockout can cause developmental brain defects, 
reduce neural cells in quantity and induce spatial 
memory disorder in mice[10]. HIF-1毩 gene deletion in the 
mesencephalic neural stem cells reduced cell survival and 
differentiation[11]. Under hypoxic condition, HIF-1毩 signal 
transduction pathway can promote the proliferation and 
differentiation of NSCs[12]. This suggests that HIF-1毩 is 
the essential physiological condition for the development of 
nervous system. 
  Erythropoietin (EPO), a target gene for HIF-1毩, exhibits 
protective effect on nerve cells, effectively alleviates 
pathological cerebral damage, and also induces neurogenesis 
after brain injury. EPO greatly reduces the infarct area of 
rats with cerebral infarction, maintains learning and memory 
abilities and significantly improves prognosis[13]. EPO can 
effectively reduce neuronal apoptosis, enlarge the soma of 
surviving neurons, increase neuronal neurites and strength 
their functions after cerebral ischemia[14]. 
  Many factors, including vascular endothelial growth factor, 
mediate post-stroke neurogenesis. VEGF is a specific potent 
mitogen for endothelial cells and a potent stimulator of 
vascular regeneration. Recent studies have demonstrated 
that VEGF plays an important role in neurogenesis. Wang 
et al[18] reported that VEGF can promote axon outgrowth 
in cultured cortical neurons. There is evidence that VEGF 
reduces infarct volume, promotes the proliferation and 
migration of neural progenitor cells in the subventricular 
zone, and thereby contributes to neurofunctional recovery[19]. 
Neurovascular niche formation plays an important role in 
neurogenesis after brain injury. 
  After ICH, endogenous NSCs in the subventricular zone 
and hippocampal dentate gyrus are activated, and the 
newly generated cells migrate toward peri-hematoma 
brain tissue and differentiate into diverse neural cells[21]. 
Results from this study showed that in the Ad-HIF-1
毩 group, DCX-positive cells in the subventricular zone 
significantly increased in quantity at 7 d after ICH, peaked 
at 14 d and then decreased gradually; a large number of 
DCX-positive cells migrated toward peri-hematoma brain 
tissue during this time period. In the Ad-HIF-1毩 group, 
the number of BrdU-positive cells in the subventricular 
zone increased at 3 d after ICH, peaked at 7 d and gradually 
decreased thereafter. The number of BrdU-positive cells 
in the Ad-HIF-1毩 group was significantly higher than 
in the PBS and Ad groups. This occurs possibly because 
HIF-1毩 can activate various target genes, promote the 
establishment of collateral circulation and improve cerebral 
microenvironment after ICH.  
  BrdU and DCX are two common markers used in the 
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study of neurogenesis. BrdU can be used to label cells in 
the S-phase of the cell cycle. A recent study has shown 
that BrdU can also label apoptotic cells. Therefore, DCX, 
a marker of new neurons, was used in this study to co-
label new neurons. In the PBS group, BrdU/DCX-positive 
cells were not detected. In the Ad-HIF-1毩 group, BrdU/
DCX-positive cells were detected in the subventricular 
zone and peri-hematoma brain tissue, accounting for 
appropriately 12% of total number of proliferated cells, and 
about 67% proliferated cells differentiate into glial cells. 
Taken together, endogenous neural stem cells proliferated, 
migrated and differentiated in rat models of ICH established 
by autologous blood injection, and HIF-1毩 gene plays an 
important role in neurogenesis after ICH. 
  This study established rat models of ICH established 
by autologous blood injection and scored neurological 
deficits of rats after Ad-HIF-1毩 administration into 
the hemorrhagic ventricle to investigate the effects of 
recombinant adenovirus-mediated HIF-1毩 gene on the 
proliferation, migration and differentiation of endogenous 
NSCs in the brain tissue and the possible mechanisms. 
Results showed that Ad-HIF-1毩 gene therapy improves 
the microenvironment of peri-hematoma tissue by up-
regulating HIF-1毩, VEGF and EPO expression levels, 
promotes the proliferation, migration and differentiation of 
endogenous NSCs, and thereby contribute to neurofunctional 
recovery after ICH. 
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